Author:
Toyama Yoichi,Yoshida Seiya,Saito Ryota,Kitamura Hiroaki,Okui Norimitsu,Miyake Ryo,Ito Ryusuke,Son Kyonsu,Usuba Teruyuki,Nojiri Takuya,Yanaga Katsuhiko
Publisher
Springer Science and Business Media LLC
Reference54 articles.
1. Malvezzi M, Bertuccio P, Levi F, La Vecchia C, Negri E: European cancer mortality predictions for the year 2012. Ann Oncol. 2012, 23: 1044-1052. 10.1093/annonc/mds024.
2. Bakkevold KE, Amesiø B, Dahl O, Kambestad B: Adjuvant combination chemotherapy (AMF) following radical resection of carcinoma of the pancreas and pappilla of Vater–results of a controlled, prospective, randomised multicentre study. Eur J Cancer. 1993, 29A: 698-703. 10.1016/S0959-8049(05)80349-1.
3. Burris HA, Moore MJ, Andersen J, Green MR, Rothenberg ML, Modiano MR, Cripps MC, Portenoy RK, Storniolo AM, Tarassoff P, Nelson R, Dorr FA, Stephens CD, Von Hoff DD: Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol. 1997, 15: 2403-2413. PMID: 9196156
4. Lygidakis NJ, Berberabe AE, Spentzouris N, Dedemadi G, Kalligas T, Loukas G, Sotiropoulou V: A prospective randomized study using adjuvant locoregional chemoimmunotherapy in combination with surgery for pancreatic carcinoma. Hepatogastroenterology. 1998, 45: 2376-2381.
5. Klinkenbijl JH, Jeekel J, Sahmoud T, van Pel R, Couvreur ML, Veenhof CH, Arnaud JP, Gonzalez DG, de Wit LT, Hennipman A, Wils J: Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group. Ann Surg. 1999, 230: 776-784. 10.1097/00000658-199912000-00006.
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献